BioXcel Therapeutics Inc (BTAI) — Financial Flexibility Index
BioXcel Therapeutics Inc (BTAI) has a Financial Flexibility Index of -0.10x as of December 2025. Free cash flow of $-14.21 Million (operating CF $-14.21 Million minus capex $0.00) represents 0% of total liabilities ($140.38 Million). Also explore net asset momentum of BioXcel Therapeutics Inc to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BioXcel Therapeutics Inc Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for BioXcel Therapeutics Inc across 11 annual periods. Check BioXcel Therapeutics Inc (BTAI) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for BioXcel Therapeutics Inc (2015–2025)
Year-by-year free cash flow to debt coverage for BioXcel Therapeutics Inc. For the full company profile including market capitalisation, see BTAI market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.41x | $-57.62 Million | $-57.62 Million | $140.38 Million | ▲ +25.1% |
| 2024 | -0.55x | $-72.03 Million | $-72.03 Million | $131.44 Million | ▲ +54.0% |
| 2023 | -1.19x | $-154.99 Million | $-155.01 Million | $130.21 Million | ▼ -13.6% |
| 2022 | -1.05x | $-135.20 Million | $-135.34 Million | $129.08 Million | ▲ +77.2% |
| 2021 | -4.60x | $-81.71 Million | $-82.15 Million | $17.77 Million | ▲ +7.8% |
| 2020 | -4.99x | $-66.03 Million | $-66.35 Million | $13.24 Million | ▼ -79.3% |
| 2019 | -2.78x | $-26.41 Million | $-27.28 Million | $9.50 Million | ▲ +1.6% |
| 2018 | -2.83x | $-13.17 Million | $-13.51 Million | $4.66 Million | ▼ -255.8% |
| 2017 | -0.79x | $-1.86 Million | $-2.20 Million | $2.34 Million | ▲ +79.6% |
| 2016 | -3.90x | $-1.29 Million | $-1.29 Million | $331.00K | ▼ -144.5% |
| 2015 | -1.59x | $-279.00K | $-280.00K | $175.00K | — |